Lupin Limited — Others, 28-03-2025: Retirement

Lupin Limited has announced a board meeting regarding the retirement of three senior management personnel: Mr. Naresh Gupta (President - API Plus & GTB), Mr. Sunil Makharia (President - Finance), and Mr. Rajender Kamboj (President - Novel Drug Discovery & Development), effective from the close of business hours on March 31, 2025. This transition may bring shifts in operational dynamics and strategic direction within the company, as the departure of experienced leaders could impact both governance and management. Investors may view this as a potential risk but also an opportunity for new leadership to drive future growth.